These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 26512839)

  • 1. Rapid improvement of pulmonary hemodynamics following combined tadalafil and inotropic treatment in a patient with pulmonary hypertension secondary to left ventricular dysfunction.
    Güvenç TS; Ekmekçi A; Sargın M; Orhan G; Eren M
    Int J Cardiol; 2016 Jan; 203():212-3. PubMed ID: 26512839
    [No Abstract]   [Full Text] [Related]  

  • 2. Dramatic improvement of clinical and hemodynamic parameters of a heart transplant candidate with sildenafil treatment.
    Gerede DM; Sayın T; Vurgun VK; Akbulut IM; Erol C
    Int J Cardiol; 2015 Apr; 185():148-9. PubMed ID: 25795206
    [No Abstract]   [Full Text] [Related]  

  • 3. Sildenafil in heart transplant candidates with pulmonary hypertension.
    de Groote P; El Asri C; Fertin M; Goéminne C; Vincentelli A; Robin E; Duva-Pentiah A; Lamblin N
    Arch Cardiovasc Dis; 2015; 108(6-7):375-84. PubMed ID: 25921840
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Taking aim at pulmonary hypertension in heart failure with preserved ejection fraction.
    Borlaug BA
    Eur Heart J; 2015 Oct; 36(38):2574-5. PubMed ID: 26188000
    [No Abstract]   [Full Text] [Related]  

  • 5. Sildenafil as an Eligible Heart Transplantation Therapy for Advanced Heart Failure Associated with Fixed Pulmonary Hypertension.
    Schwartzmann P
    Arq Bras Cardiol; 2021 Feb; 116(2):227-228. PubMed ID: 33656069
    [No Abstract]   [Full Text] [Related]  

  • 6. Effects of sildenafil on invasive haemodynamics and exercise capacity in heart failure patients with preserved ejection fraction and pulmonary hypertension: a randomized controlled trial.
    Hoendermis ES; Liu LC; Hummel YM; van der Meer P; de Boer RA; Berger RM; van Veldhuisen DJ; Voors AA
    Eur Heart J; 2015 Oct; 36(38):2565-73. PubMed ID: 26188003
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exercise-induced pulmonary artery hypertension in a patient with compensated cardiac disease: hemodynamic and functional response to sildenafil therapy.
    Nikolaidis L; Memon N; O'Murchu B
    Tex Heart Inst J; 2015 Feb; 42(1):50-4. PubMed ID: 25873799
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hemodynamic effects of sildenafil in patients with congestive heart failure and pulmonary hypertension: combined administration with inhaled nitric oxide.
    Lepore JJ; Maroo A; Bigatello LM; Dec GW; Zapol WM; Bloch KD; Semigran MJ
    Chest; 2005 May; 127(5):1647-53. PubMed ID: 15888841
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the therapeutic effects and side effects of tadalafil and sildenafil after surgery in young infants with pulmonary arterial hypertension due to systemic-to-pulmonary shunts.
    Sabri MR; Bigdelian H; Hosseinzadeh M; Ahmadi A; Ghaderian M; Shoja M
    Cardiol Young; 2017 Nov; 27(9):1686-1693. PubMed ID: 28994364
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of bolus milrinone on hemodynamic variables and pulmonary vascular resistance in patients with severe left ventricular dysfunction: a rapid test for reversibility of pulmonary hypertension.
    Givertz MM; Hare JM; Loh E; Gauthier DF; Colucci WS
    J Am Coll Cardiol; 1996 Dec; 28(7):1775-80. PubMed ID: 8962566
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pattern of resolution of pulmonary hypertension, long-term allograft right ventricular function, and exercise capacity in high-risk heart transplant recipients listed under oral sildenafil.
    De Santo LS; Buonocore M; Agrusta F; Bancone C; Galdieri N; Romano G; Maiello C; Amarelli C
    Clin Transplant; 2014 Jul; 28(7):837-43. PubMed ID: 24828060
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Response to Sildenafil in a Patient With Coexisting Post-Liver Transplant Portopulmonary Hypertension and Hepatopulmonary Syndrome.
    Turgeon RD; Hussaini T; Partovi N; Erb SR; Nador R; Marquez Azalgara V; Yoshida E
    Exp Clin Transplant; 2017 Dec; 15(6):693-695. PubMed ID: 27001306
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reversal of right-ventricular dysfunction in pulmonary arterial hypertension following sildenafil therapy.
    Romano S; Chung J; Farzaneh-Far A
    Eur Heart J; 2015 Aug; 36(30):2018. PubMed ID: 25713316
    [No Abstract]   [Full Text] [Related]  

  • 14. Soluble guanylate cyclase stimulator riociguat and phosphodiesterase 5 inhibitor sildenafil ameliorate pulmonary hypertension due to left heart disease in mice.
    Pradhan K; Sydykov A; Tian X; Mamazhakypov A; Neupane B; Luitel H; Weissmann N; Seeger W; Grimminger F; Kretschmer A; Stasch JP; Ghofrani HA; Schermuly RT
    Int J Cardiol; 2016 Aug; 216():85-91. PubMed ID: 27140341
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sarcoidosis-associated pulmonary hypertension treated with sildenafil - a case report.
    Kacprzak A; Szturmowicz M; Burakowska B; Franczuk M; Kober J; Kurzyna M; Wilk M; Szmit S; Torbicki A; Kuś J
    Adv Respir Med; 2017; 85(5):258-263. PubMed ID: 29083021
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of chronic sildenafil use on pulmonary hemodynamics and clinical outcomes in heart transplantation.
    Pons J; Leblanc MH; Bernier M; Cantin B; Bourgault C; Bergeron S; Proulx G; Morin J; Nalli C; O'Connor K; Chateauvert N; Sénéchal M
    J Heart Lung Transplant; 2012 Dec; 31(12):1281-7. PubMed ID: 23127754
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment and Prognosis of Pulmonary Hypertension in the Left Ventricular Assist Device Patient.
    Jensen CW; Goldstone AB; Woo YJ
    Curr Heart Fail Rep; 2016 Jun; 13(3):140-50. PubMed ID: 27241336
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral Tadalafil in Children with Pulmonary Arterial Hypertension.
    Shiva A; Shiran M; Rafati M; Zamani H; Babazadeh K; Saeedi M; Ala S
    Drug Res (Stuttg); 2016 Jan; 66(1):7-10. PubMed ID: 25611962
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of sildenafil in acute posttransplant right ventricular dysfunction: successful experience in 13 consecutive patients.
    De Santo LS; Mastroianni C; Romano G; Amarelli C; Marra C; Maiello C; Galdieri N; Della Corte A; Cotrufo M; Caianiello G
    Transplant Proc; 2008; 40(6):2015-8. PubMed ID: 18675118
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk-benefit considerations when prescribing phosphodiesterase-5 inhibitors in children.
    Magee AG; Makhecha S; Bentley S
    Expert Opin Drug Saf; 2015 May; 14(5):633-42. PubMed ID: 25746065
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.